Expand / Collapse search
Watch TV
☰

Quotes displayed in real-time or delayed by at least 15 minutes. Market data provided by Factset. Powered and implemented by FactSet Digital Solutions.  Legal Statement.

This material may not be published, broadcast, rewritten, or redistributed. ©2025 FOX News Network, LLC. All rights reserved. FAQ - New Privacy Policy

swedish orphan biovitrum ab - SWOBY

SWOBY

Close Chg Chg %
18.20 -0.40 -2.20%

Open Market

17.80

-0.40 (2.20%)

Volume: 108.00

Last Updated:

Dec 11, 2025, 9:38 AM EDT

Trade Now

Company Overview: swedish orphan biovitrum ab - SWOBY

SWOBY Key Data

Open

$17.80

 Day Range

17.80 - 17.80

52 Week Range

12.75 - 18.20

 Market Cap

$12.21B

Shares Outstanding

689.31M

 Public Float

N/A

Beta

1.01

 Rev. Per Employee

N/A

P/E Ratio

N/A

 EPS

-$0.04

Yield

0.00%

 Dividend

$0.45

EX-DIVIDEND DATE

Sep 21, 2023

 SHORT INTEREST

N/A

AVERAGE VOLUME

426.43

  

SWOBY Performance

No Data Available

SWOBY Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 15
Full Ratings ➔
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Swedish Orphan Biovitrum Ab - SWOBY

Collapse All in section
All values USD millions. 2021 2022 2023 2024 5-year trend
Sales/Revenue
1.81B 1.86B 2.08B 2.46B
Sales Growth
+9.11% +2.64% +12.24% +18.12%
Cost of Goods Sold (COGS) incl D&A
634.74M 644.67M 760.27M 889.84M
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
232.86M 224.61M 298.51M 352.23M
Depreciation
18.40M 15.32M 17.14M 15.32M
Amortization of Intangibles
214.45M 209.29M 281.37M 336.90M
COGS Growth
+12.10% +1.57% +17.93% +17.04%
Gross Income
1.17B 1.21B 1.32B 1.57B
Gross Income Growth
+7.55% +3.23% +9.22% +18.74%
Gross Profit Margin
+64.91% +65.28% +63.52% +63.85%
2021 2022 2023 2024 5-year trend
SG&A Expense
735.61M 764.63M 885.18M 1.02B
Research & Development
229.94M 219.27M 256.12M 331.32M
Other SG&A
505.67M 545.36M 629.05M 690.64M
SGA Growth
+21.17% +3.94% +15.77% +15.45%
Other Operating Expense
- - - -
-
Unusual Expense
815.41K 70.65M 45.59M 18.44M
EBIT after Unusual Expense
437.76M 376.78M 392.99M 531.46M
Non Operating Income/Expense
(5.13M) (3.26M) (10.08M) 2.65M
Non-Operating Interest Income
- 494.08K 2.54M 3.03M
Equity in Earnings of Affiliates
- - - -
-
Interest Expense
48.81M 45.36M 104.65M 117.28M
Interest Expense Growth
-7.75% -7.07% +130.74% +12.07%
Gross Interest Expense
48.81M 45.36M 104.65M 117.28M
Interest Capitalized
- - - -
-
Pretax Income
383.82M 328.17M 278.26M 416.83M
Pretax Income Growth
-16.22% -14.50% -15.21% +49.80%
Pretax Margin
+21.22% +17.67% +13.35% +16.93%
Income Tax
71.76M 67.49M 51.34M 49.94M
Income Tax - Current - Domestic
76.76M 62.06M 36.55M 115.30M
Income Tax - Current - Foreign
- - - -
-
Income Tax - Deferred - Domestic
(5.01M) 5.43M 14.79M (65.36M)
Income Tax - Deferred - Foreign
- - - -
-
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
312.07M 260.67M 226.92M 366.89M
Minority Interest Expense
- - - (567.50K)
-
Net Income
312.07M 260.67M 226.92M 367.45M
Net Income Growth
-11.48% -16.47% -12.95% +61.93%
Net Margin Growth
+17.25% +14.04% +10.89% +14.93%
Extraordinaries & Discontinued Operations
- - - -
-
Discontinued Operations
- - - -
-
Net Income After Extraordinaries
312.07M 260.67M 226.92M 367.45M
Preferred Dividends
- - - -
-
Net Income Available to Common
312.07M 260.67M 226.92M 367.45M
EPS (Basic)
0.5051 0.4212 0.3516 0.535
EPS (Basic) Growth
-11.60% -16.61% -16.52% +52.16%
Basic Shares Outstanding
617.80M 618.96M 645.32M 686.89M
EPS (Diluted)
0.5022 0.4171 0.3481 0.5317
EPS (Diluted) Growth
-11.23% -16.95% -16.54% +52.74%
Diluted Shares Outstanding
621.46M 624.91M 651.94M 691.12M
EBITDA
671.43M 672.04M 737.10M 902.13M
EBITDA Growth
-4.68% +0.09% +9.68% +22.39%
EBITDA Margin
+37.12% +36.19% +35.37% +36.65%

Snapshot

Average Recommendation OVERWEIGHT Average Target Price 19.14
Number of Ratings 15 Current Quarters Estimate 0.215
FY Report Date 03 / 2026 Current Year's Estimate 0.989
Last Quarter’s Earnings 0.206 Median PE on CY Estimate N/A
Year Ago Earnings 0.25 Next Fiscal Year Estimate 1.274
Median PE on Next FY Estimate N/A

Earnings Per Share

This Quarter Next Quarter This Fiscal Next Fiscal
# of Estimates 1 1 11 11
Mean Estimate 0.21 0.22 0.99 1.27
High Estimates 0.21 0.22 1.22 1.57
Low Estimate 0.21 0.22 0.74 1.07
Coefficient of Variance N/A N/A 15.55 13.13

Analysts Recommendations

Current 1 Month Ago 3 Months Ago
BUY 9 9 8
OVERWEIGHT 1 1 2
HOLD 4 4 4
UNDERWEIGHT 0 0 0
SELL 1 1 1
MEAN Overweight Overweight Overweight

Swedish Orphan Biovitrum Ab in the News